Skip to main content
eScholarship
Open Access Publications from the University of California

UCLA School of Law

UCLA Public Law & Legal Theory Series bannerUCLA

The Case for Addressing Ecological Risk from Emerging Biotechnologies and an Agenda for Future Reforms

Abstract

In 2022, President Biden signed an executive order promoting the development of biotechnology, but also suggesting the importance of biodiversity and ecological health in biotechnology regulation. Even after the executive order, however, the Coordinated Framework for biotechnology regulation wholly fails to address the ecological risks posed by what we term “synthetic conservation,” that is, the use of genetically engineered organisms created for intentional release into nature. Notably, the Coordinated Framework continues to exclude from any real role agencies that have expertise regarding biodiversity and ecological health. The executive order also in no way challenges an implicit assumption of the Coordinated Framework: that all biotechnology, even genetically engineered animals that may be designed to replace non-engineered species, are “products” that need to be reviewed only for their safety as “products” and even then, only when they are first allowed onto the market. We propose and consider a number of Federal Executive Branch, state law, and international law paths to bringing an ecology-informed realism to U.S. regulation regarding genetically engineered animals created for environmental release—a realism that centers ecological well-being over time as a key goal and counters the hegemony of the product model. Despite its shortcomings, the Biden Order could be the jumping-off point for efforts to achieve the needed reforms to address current and emerging alterations of wildlife and the ecosystems they inhabit and will inhabit.